Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM and EGM

19 Apr 2013 14:13

RNS Number : 8115C
3Legs Resources plc
19 April 2013
 



19 April 2013

 

 

3Legs Resources plc

 

Results of Annual General Meeting and Extraordinary General Meeting

 

At the Annual General Meeting of 3Legs Resources plc (the "Company") held today, Resolutions number 1 to 4 contained in the Notice of Annual General Meeting and put to the meeting were duly approved. Resolution number 5, which was proposed as a special resolution, was not approved.

 

At the Extraordinary General Meeting of 3Legs Resources plc held today, all the Resolutions contained in the Notice of Extraordinary General Meeting and put to the meeting were rejected, as recommended by the Board.

 

All the resolutions were decided by way of a poll. Details of the votes cast were as follows:

 

a) Annual General Meeting

 

Resolution

In favour

Against

Withheld

1

58,821,339

2,124,900

12,000,500

2

58,820,620

2,126,119

12,000,000

3

70,820,620

2,126,119

0

4

58,821,839

2,124,900

12,000,000

5

45,691,839

27,054,900

200,000

 

b) Extraordinary General Meeting

 

Resolution

In favour

Against

Withheld

1

34,409,584

44,812,911

320,000

2

32,735,588

46,806,907

0

3

32,735,588

46,806,907

0

4

34,662,916

44,879,579

0

5

32,492,916

47,049,579

0

6

32,735,588

46,806,907

0

7

34,662,916

44,879,579

0

 

 

Tim Eggar, Chairman of the Company, commented, "We are delighted with the results of the Extraordinary General Meeting, which is the result of the second EGM requisition notice we have had to deal with in 6 months. Both EGM requisitions had similar objectives and we have had to incur considerable expense, both in terms of Board and management time and in terms of advisers' costs, to respond to them in the appropriate fashion.

 

We believe the results of the Extraordinary General Meeting clearly demonstrate that the majority of our shareholders, representing in excess of 56% of votes cast, continue to support the Board's belief in the significant potential of our Polish Baltic Basin concessions. We confirm that we are proceeding with our previously announced work programme, as agreed with ConocoPhillips, and we look forward to seeing the results in due course."

 

 

For further information please contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Kamlesh Parmar, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies Hoare Govett

Tel:

+44 207 029 8000

Simon Hardy

Jamie Buckland

Northland Capital Partners

Tel:

+44 207 796 8800

Louis Castro

Matthew Johnson

College Hill

Tel:

+44 207 457 2020

Matthew Tyler

Catherine Wickman

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKAOROAASAAR
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.